|
BioNJ's Statement on SCOTUS Mifepristone Ruling
"BioNJ is heartened that the Supreme Court has decided to ensure access to mifepristone, as the alternative would have impeded a pregnant person’s right to choose. Importantly, it also would have jeopardized the FDA’s authority and decision-making, fundamentally undermining the scientific basis by which they determine safety and efficacy of medications. We realize that this conversation may not be over but we applaud the Supreme Court’s decision today."
| 
